Why Tilray Stock Plummeted by 26% in April
The marijuana sector, beset by a host of tough challenges, has been out of favor with investors for years. That looks unlikely to change as long as the drug remains illegal at the federal level, and even that might not save some of the market's players. One of the cannabis companies trying mightily to succeed is Tilray Brands (NASDAQ: TLRY), which shed more than 26% of its value in April.Those challenges are a constant drag. Meanwhile, Tilray has been attempting to cope with difficulties unique to it lately.The company didn't start April on an up note. In the early part of the month, it published its fiscal third-quarter 2025 results, showing a 1% year-over-year decline in net revenue to just under $186 million. Worse, it posted a non-GAAP (adjusted) loss of $2.9 million after netting an $885,000 profit in the same period the previous year.Continue reading
The marijuana sector, beset by a host of tough challenges, has been out of favor with investors for years. That looks unlikely to change as long as the drug remains illegal at the federal level, and even that might not save some of the market's players. One of the cannabis companies trying mightily to succeed is Tilray Brands (NASDAQ: TLRY), which shed more than 26% of its value in April.
Those challenges are a constant drag. Meanwhile, Tilray has been attempting to cope with difficulties unique to it lately.
The company didn't start April on an up note. In the early part of the month, it published its fiscal third-quarter 2025 results, showing a 1% year-over-year decline in net revenue to just under $186 million. Worse, it posted a non-GAAP (adjusted) loss of $2.9 million after netting an $885,000 profit in the same period the previous year.
